We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Qualasept Ltd t/a Bath ASU is recalling a specific batch of Irinotecan 200mg/260mL in sodium chloride 0.9% w/v intravenous infusion and specific batches of Infliximab (Remsima) Intravenous infusion in Sodium Chloride 0.9%w/v due to risks of reduced product quality.
The CMA has today issued a statement of objections to the pharmaceutical company Merck Sharp & Dohme Limited (MSD).
CMA closes investigation into drug firm MSD’s discount scheme.
A summary of recent letters, medicine recalls and notifications sent to healthcare professionals.
Upper Tribunal Administrative Appeals Chamber decision by Judge Poole on 1 April 2019.
Risk of tuberculosis - screen all patients before starting treatment and monitor them closely.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.